The prevalence of central nervous system (CNS) neurologic dysfunction associated with human immunodeficiency virus (HIV) infection continues to increase, despite the use of antiretroviral therapy. Previous work has focused on the deleterious effects of HIV on mature neurons and on development of neuroprotective strategies, which have consistently failed to show a meaningful clinical benefit. It is now well established that new neurons are continuously generated in discrete regions in the adult mammalian brain, and accumulating evidence supports important roles for these neurons in specific cognitive functions. In a transgenic mouse model of HIV neurologic disease with glial expression of the HIV envelope protein gp120, we demonstrate a significant reduction in proliferation of hippocampal neural progenitors in the dentate gyrus of adult animals, resulting in a dramatic decrease in the number of newborn neurons in the adult brain. We identify amplifying neural progenitor cells (ANPs) as the first class of progenitors affected by gp120, and we also demonstrate that newly generated neurons exhibit aberrant dendritic development. Furthermore, voluntary exercise and treatment with a selective serotonin reuptake inhibitor increase the ANP population and rescue the observed deficits in gp120 transgenic mice. Thus, during HIV infection, the envelope protein gp120 may potently inhibit adult hippocampal neurogenesis, and neurorestorative approaches may be effective in ameliorating these effects. Our study has significant implications for the development of novel therapeutic approaches for HIV-infected individuals with neurologic dysfunction and may be applicable to other neurodegenerative diseases in which hippocampal neurogenesis is impaired.
Introduction
Soon after the discovery of the human immunodeficiency virus (HIV) it was realized that the virus may cause a dementing illnesss (Navia et al., 1986) and that it may enter the brain early in the course of infection. With the availability of combination antiretroviral therapies, the severity of neurocognitive impairment has become milder but the prevalence continues to increase (Sacktor, 2002) . In recent years closer attention has been paid to the asymptomatic and milder forms of neurologic impairment. In a recent study, the prevalence of HIV associated neurocognitive disorders (HAND) in aviremic patients was 84% among patients with cognitive complaints and 64% among noncomplainers (Simioni et al., 2010) . While it is widely accepted that neuroprotective strategies are needed to treat HAND, to date this approach has shown little or no effect (McArthur et al., 2005) , in part because the underlying substrate mediating neurologic dysfunction remains poorly understood. While much attention has previously focused on frontostriatal dysfunction in HIV infection (Chang et al., 2001; Ernst et al., 2002) , the hippocampus is increasingly recognized as an important target of HIV-mediated neurotoxicity. The presence of atrophy, high viral loads, neuronal cell loss, and functional MRI abnormalities in the hippocampus of HIV-infected patients suggests that the hippocampus may be a target of HAND (Archibald et al., 2004; Castelo et al., 2006; Sa et al., 2004; Wiley et al., 1998) .
Within the dentate gyrus of the adult hippocampus, new granule cells are continuously generated throughout life in all mammals studied, including humans (Johnson et al., 2009; Lledo et al., 2006; Ming and Song, 2005a; Zhao et al., 2008) . Neurogenesis involves a coordinated series of steps including proliferation, survival and differentiation of neural progenitor cells (NPC) and maturation of newly generated neurons (Duan et al., 2008; Johnson et al., 2009; Lledo et al., 2006; Zhao et al., 2008) . While the exact functions of adult neurogenesis are still elusive, rapidly accumulating evidence from behavioral analyses supports a contribution of new neurons in the adult brain to learning, memory and cognition (Kempermann et al., Neurobiology of Disease 41 (2011) 678-687 
